Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CL(pro) covalent inhibitors

Severe diseases such as the ongoing COVID-19 pandemic, as well as the previous SARS and MERS outbreaks, are the result of coronavirus infections and have demonstrated the urgent need for antiviral drugs to combat these deadly viruses. Due to its essential role in viral replication and function, 3CL(...

Descripción completa

Detalles Bibliográficos
Autores principales: Stille, Julia K., Tjutrins, Jevgenijs, Wang, Guanyu, Venegas, Felipe A., Hennecker, Christopher, Rueda, Andrés M., Sharon, Itai, Blaine, Nicole, Miron, Caitlin E., Pinus, Sharon, Labarre, Anne, Plescia, Jessica, Burai Patrascu, Mihai, Zhang, Xiaocong, Wahba, Alexander S., Vlaho, Danielle, Huot, Mitchell J., Schmeing, T. Martin, Mittermaier, Anthony K., Moitessier, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665847/
https://www.ncbi.nlm.nih.gov/pubmed/34995923
http://dx.doi.org/10.1016/j.ejmech.2021.114046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665847/
https://www.ncbi.nlm.nih.gov/pubmed/34995923
http://dx.doi.org/10.1016/j.ejmech.2021.114046

Ejemplares similares